Αποτελέσματα Αναζήτησης
up-to-date review of the status of the tuberculosis epidemic, recommended diagnostics, drug treatments and vaccines, progress in delivery of care and prevention, progress in research and development, and actions needed to accelerate
After a rapid review of epidemiology and risk factors, the clinical priorities on MDR-TB diagnosis (including whole genome sequencing and drug-susceptibility testing interpretations) and treatment (treatment design and management, TB in children) are discussed.
29 Ιαν 2022 · This perspective links to Zumla's priorities in global health, notably his creation and co-directorship of the Pan-African Network For Rapid Research, Response, Relief and Preparedness for Infectious Disease Epidemics (PANDORA-ID-NET).
Tuberculosis. Alimuddin Zumla, M.D., Ph.D., Mario Raviglione, M.D., Richard Hafner, M.D., and C. Fordham von Reyn, M.D. Despite. the availability of a cheap and effective treatment, tu-...
Ali Zumla: respiratory medicine and global health supremo. Whether it is in his clinical work or endeavouring to connect colleagues across continents for future pandemic preparedness, Ali Zumla is motivated by improving patient care and the health of neglected populations.
30 Απρ 2013 · Here, Zumla, Nahid and Cole discuss current concepts and recent advances in TB drug discovery, development and clinical trial evaluation, and provide an update of new agents and approaches ...
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a global public health threat. A significant challenge for TB control efforts has been the monitoring of TB therapy and determination of TB treatment success. Current recommendations for TB treatment monitoring rely on sputum and culture conversion, which have ...
